Analyst Ratings For Tabula Rasa HealthCare (NASDAQ:TRHC)
Today, Chardan Capital raised its price target on Tabula Rasa HealthCare (NASDAQ:TRHC) to $50.00 per share.
Some recent analyst ratings include
- 3/13/2018-CIBC Reiterated Rating of Outperform .
- 3/13/2018-William Blair Reiterated Rating of Outperform.
- 1/4/2018-Citigroup initiated coverage with a Buy rating.
- 11/1/2017-First Analysis initiated coverage with a Overweight rating.
Recent Insider Trading Activity For Tabula Rasa HealthCare (NASDAQ:TRHC)
Tabula Rasa HealthCare (NASDAQ:TRHC) has insider ownership of 45.80% and institutional ownership of 53.03%.
- On 3/13/2018 Bruce Luehrs, Director, sold 16,745 with an average share price of $37.63 per share and the total transaction amounting to $630,114.35.
- On 3/9/2018 Bruce Luehrs, Director, sold 15,664 with an average share price of $37.09 per share and the total transaction amounting to $580,977.76.
- On 3/7/2018 Calvin H Knowlton, CEO, sold 8,000 with an average share price of $35.59 per share and the total transaction amounting to $284,720.00.
- On 3/6/2018 Bruce Luehrs, Director, sold 3,115 with an average share price of $36.03 per share and the total transaction amounting to $112,233.45.
- On 2/22/2018 Bruce Luehrs, Director, sold 252,242 with an average share price of $34.29 per share and the total transaction amounting to $8,649,378.18.
- On 2/7/2018 Calvin H Knowlton, CEO, sold 8,000 with an average share price of $34.75 per share and the total transaction amounting to $278,000.00.
- On 1/12/2018 Brian W Adams, CFO, bought 5,391 with an average share price of $14.23 per share and the total transaction amounting to $76,713.93.
Recent Trading Activity for Tabula Rasa HealthCare (NASDAQ:TRHC)
Shares of Tabula Rasa HealthCare closed the previous trading session at 34.06 up +0.44 1.31% with 33.650001525878906 shares trading hands.